http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103393689-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e328f3403a32b1dbb56db1d343f262f5 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4172 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 2013-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5162cebd8e673a9e453a73eb340a9deb |
| publicationDate | 2014-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103393689-B |
| titleOfInvention | Pharmaceutical composition of cefotiam hydrochloride for injection and compound amino acid injection |
| abstract | The invention relates to a pharmaceutical composition of cefotiam hydrochloride for injection and compound amino acid injection, and especially relates to an application product of the pharmaceutical composition, wherein the application product comprises cefotiam hydrochloride for injection and compound amino acid injection. Administration method comprises following steps, 0.25 to 2g of cefotiam hydrochloride for injection is dissolved in appropriate amount of compound amino acid injection, and the mixture is applied to 30min to 2h of intravenous drop infusion, wherein 0.25 to 2g of cefotiam hydrochloride is the dosage of one time. Compared with a method of compatible mixing application of cefotiam hydrochloride for injection and compound amino acid injection, the pharmaceutical composition is capable of simplifying steps, improving safety, and increasing clinical application quality and bioavailability of medicines, and possesses significant benefits on the stability of cefotiam hydrochloride. |
| priorityDate | 2013-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 140.